Owner Boehringer Ingelheim International GmbH

Inventors Steegmaier, Martin; Quant, Jens, Juergen; Baum, Anke; Herfurth, Lars; Solca, Flavio; Guertler, Ulrich; Reiser, Ulrich; Zahn, Stephan Karl; Stadtmueller, Heinz; Schoop, Andreas; Hauptmann, Rudolf; Engelhardt, Harald

Agent Davies Collison Cave

Pub. Number AU-B-2005276500

PCT Pub. Number WO2006/021544

Priority 04019775.8 20.08.04 EP

Filing date 18 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 10 May 2012

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5513 (2006.01)

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms